Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 30, 2023	Jul. 31, 2022
Cash flows from operating activities:
Net income	$ 136,478	$ 123,978
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	59,523	61,210
Share-based compensation	5,874	4,623
Changes in assets and liabilities:
Accounts receivable	(1,482)	(45,199)
Inventories	(2,693)	1,570
Other current assets	4,053	661
Accounts payable, accrued liabilities, and other	(6,197)	49,078
Net cash provided by operating activities	195,556	195,921
Cash flows from investing activities:
Purchases of property, plant and equipment	(78,813)	(46,337)
Purchases of available-for-sale debt securities	(9,837)	0
Proceeds from maturities of available-for-sale debt securities	22,500	0
Government incentives	2,033	1,394
Other	(116)	(179)
Net cash used in investing activities	(64,233)	(45,122)
Cash flows from financing activities:
Repayments of debt	(16,351)	(51,917)
Purchases of treasury stock	0	(2,522)
Contribution from noncontrolling interest	0	24,995
Proceeds from share-based arrangements	1,241	5,505
Net settlements of restricted stock awards	(1,292)	(1,463)
Net cash used in financing activities	(16,402)	(25,402)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	13,813	(21,308)
Net increase in cash, cash equivalents, and restricted cash	128,734	104,089
Cash, cash equivalents, and restricted cash at beginning of period	322,409	279,680
Cash, cash equivalents, and restricted cash at end of period	451,143	383,769
Less: Ending restricted cash	2,664	2,936
Cash and cash equivalents at end of period	448,479	380,833
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased during the period	$ 22,578	$ 5,558